Patient experience

We helped a pharmaceutical player to structure a care pathway using the “patient tracer” methodology, which consists of retrospectively analyzing the pathway of a limited sample of patients, in order to diagnose areas for improvement and identify possible solutions for better care.

By analyzing the profiles of tracer patients and reconstructing their theoretical pathways, and carrying out an investigation with the key players in care (doctors, nurses, etc.), we were able to propose solutions to improve the patient experience, which we then developed in an action plan to improve the care pathway in this pathology based on the experience of the patients.

Our client, a world leader in the pharmaceutical industry, wanted to accelerate the deployment of a program created to improve adherence to type II diabetes treatments, based on a better understanding of the patient experience, in a “Value Based Healthcare” approach.

Thanks to a field investigation with healthcare providers, we helped our client identify the indicators of value for the patients to be measured along the care pathway. We then recommended to our client a qualified list of potential partners in order to acquire the data management skills necessary to set up such a “value-based” model.

We supported a pharmaceutical player in the development of a digital support offer for patients with Crohn’s disease. Our client wanted to understand what the major issues in the patient experience were and what levers could help address them, in order to develop their solution accordingly.

By identifying and prioritizing obstacles in the treatment process for this disease during a workshop with patients and by co-defining operational solutions to improve and develop the quality of life and well-being of patients, Alcimed enabled its client to develop a solid action plan to create a new Patient Support Program to improve the patient experience.

Our team helped a leading pharmaceutical player to understand the emotions experienced by patients with a rare disease in order to develop a range of services to improve their well-being and quality of life.

After mapping patients’ emotions throughout their care pathways (from pre-diagnosis to palliative care) in several European countries, our team carried out a benchmark of services intended for patients, before selecting, during a workshop with our client’s teams, ideas for services to be put in place to respond to the emotional challenges identified with patients.

We worked with a pharmaceutical client to understand the impact of their new innovative treatment in France on the management of a rare genetic disease and on the patient journey.

We started by analyzing the impact of the treatment on disease management (symptom intensity, other treatments, frequency of visits to the doctor, etc.), patients’ lives (quality of life, life expectancy, etc.) and other potential evolutions in the care management, through desk research and interviews with patients. We then turned the outputs of our investigations ito concrete actions during several workshops with key internal stakeholders and a patient association.

This multi-stakeholder project enabled our client to connect with key stakeholders such as patient associations and understand the impact of their treatment in the management of this rare genetic disease. We also provided them with key factors to keep in mind to maximize the adherence and utilization of their treatment, from the perspective of patients.

We supported a pharmaceutical company by performing a worldwide landscaping of the concept of Patient Engagement: who, what and why, with concrete examples from other pharmaceutical players.

To do so, we first conducted a literature in-depth analysis and targeted interviews with patients and pharmaceutical players. We were thus able to contextualize Patient Engagement: definition, origin, more mature therapeutic areas, etc. Then, we analyzed the players within patients communities (patient organizations, patient experts, etc.), their roles and influence on patient engagement. Finally, we identified the benefits, opportunities and potential levers for our client to work on patient engagement, along with concrete examples of actions taken by competing companies across the value chain.

The project output for our client was a comprehensive vision of Patient Engagement, why it is now a pillar of pharmaceutical business and how it will evolve in the future. We also helped our client promote the project internally, raise awareness on this concept’s value and get teams on board via an internal roadshow.